SE7714123L - Forfarande for framstellning av imidazolderivat - Google Patents
Forfarande for framstellning av imidazolderivatInfo
- Publication number
- SE7714123L SE7714123L SE7714123A SE7714123A SE7714123L SE 7714123 L SE7714123 L SE 7714123L SE 7714123 A SE7714123 A SE 7714123A SE 7714123 A SE7714123 A SE 7714123A SE 7714123 L SE7714123 L SE 7714123L
- Authority
- SE
- Sweden
- Prior art keywords
- immediation
- procedure
- imidazole derivatives
- imidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/42—One oxygen atom attached in position 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB53538/76A GB1596376A (en) | 1976-12-22 | 1976-12-22 | 4,5-disubstituted imidazole-2-thiones processes for their preparation and their use as intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7714123L true SE7714123L (sv) | 1978-06-23 |
Family
ID=10468162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7714123A SE7714123L (sv) | 1976-12-22 | 1977-12-13 | Forfarande for framstellning av imidazolderivat |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4166184A (xx) |
| JP (1) | JPS5379863A (xx) |
| AU (1) | AU514770B2 (xx) |
| BE (1) | BE862095A (xx) |
| CA (1) | CA1096388A (xx) |
| DE (1) | DE2755749A1 (xx) |
| DK (1) | DK559877A (xx) |
| ES (1) | ES465346A1 (xx) |
| FI (1) | FI773592A (xx) |
| FR (1) | FR2375219A1 (xx) |
| GB (1) | GB1596376A (xx) |
| HU (1) | HU177745B (xx) |
| IE (1) | IE46493B1 (xx) |
| IL (1) | IL53350A (xx) |
| LU (1) | LU78725A1 (xx) |
| NL (1) | NL7714261A (xx) |
| NO (1) | NO774407L (xx) |
| PH (1) | PH14357A (xx) |
| PT (1) | PT67276B (xx) |
| SE (1) | SE7714123L (xx) |
| ZA (1) | ZA776538B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0170872B1 (de) * | 1984-07-13 | 1989-08-23 | Bayer Ag | Verfahren zur Herstellung, von 3,7-Bisacetaminoheptanon-2 |
| EP0428849A3 (en) * | 1989-09-28 | 1991-07-31 | Hoechst Aktiengesellschaft | Retroviral protease inhibitors |
| US7767826B2 (en) * | 2007-10-05 | 2010-08-03 | Pharmatech International, Inc. | Process for the synthesis of L-(+)-ergothioneine |
| CN109956881A (zh) * | 2017-12-26 | 2019-07-02 | 上海凯赛生物技术研发中心有限公司 | 一种苯甲酰戊二胺及其制备和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2585388A (en) * | 1948-11-17 | 1952-02-12 | Lilly Co Eli | Preparation of 2-mercaptoimidazoles |
| GB1054708A (xx) * | 1964-10-02 |
-
1976
- 1976-12-22 GB GB53538/76A patent/GB1596376A/en not_active Expired
-
1977
- 1977-11-03 ZA ZA00776538A patent/ZA776538B/xx unknown
- 1977-11-10 IL IL53350A patent/IL53350A/xx unknown
- 1977-11-14 PT PT67276A patent/PT67276B/pt unknown
- 1977-11-22 PH PH20461A patent/PH14357A/en unknown
- 1977-11-28 FI FI773592A patent/FI773592A/fi not_active Application Discontinuation
- 1977-12-08 US US05/858,488 patent/US4166184A/en not_active Expired - Lifetime
- 1977-12-13 SE SE7714123A patent/SE7714123L/xx unknown
- 1977-12-14 AU AU31572/77A patent/AU514770B2/en not_active Expired
- 1977-12-14 DE DE19772755749 patent/DE2755749A1/de not_active Withdrawn
- 1977-12-14 FR FR7737607A patent/FR2375219A1/fr active Granted
- 1977-12-15 JP JP15159477A patent/JPS5379863A/ja active Pending
- 1977-12-15 DK DK559877A patent/DK559877A/da unknown
- 1977-12-16 IE IE2568/77A patent/IE46493B1/en unknown
- 1977-12-20 LU LU78725A patent/LU78725A1/xx unknown
- 1977-12-21 HU HU77SI1607A patent/HU177745B/hu unknown
- 1977-12-21 NO NO774407A patent/NO774407L/no unknown
- 1977-12-21 BE BE183657A patent/BE862095A/xx unknown
- 1977-12-21 CA CA293,537A patent/CA1096388A/en not_active Expired
- 1977-12-22 NL NL7714261A patent/NL7714261A/xx not_active Application Discontinuation
- 1977-12-22 ES ES465346A patent/ES465346A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI773592A (fi) | 1978-06-23 |
| IL53350A0 (en) | 1978-01-31 |
| IE46493B1 (en) | 1983-06-29 |
| ZA776538B (en) | 1978-08-30 |
| LU78725A1 (xx) | 1978-04-17 |
| DE2755749A1 (de) | 1978-06-29 |
| PT67276A (en) | 1977-12-01 |
| AU3157277A (en) | 1979-06-21 |
| US4166184A (en) | 1979-08-28 |
| AU514770B2 (en) | 1981-02-26 |
| PT67276B (en) | 1979-04-18 |
| PH14357A (en) | 1981-06-03 |
| NL7714261A (nl) | 1978-06-26 |
| GB1596376A (en) | 1981-08-26 |
| IL53350A (en) | 1981-10-30 |
| CA1096388A (en) | 1981-02-24 |
| FR2375219B1 (xx) | 1981-02-27 |
| IE46493L (en) | 1978-06-22 |
| ES465346A1 (es) | 1978-09-16 |
| HU177745B (en) | 1981-12-28 |
| NO774407L (no) | 1978-06-23 |
| BE862095A (fr) | 1978-06-21 |
| DK559877A (da) | 1978-06-23 |
| FR2375219A1 (fr) | 1978-07-21 |
| JPS5379863A (en) | 1978-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE420314B (sv) | Analogiforfarande for framstellning av indolizinderivat | |
| NO147985C (no) | Fremgangsmaate for fremstilling av meta-aryloksybenzaldehyder | |
| NO821848L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| SE433212B (sv) | Forfarande for framstellning av 4-hydroxi-aporfin-derivat | |
| SE437833B (sv) | Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner | |
| FI773738A (fi) | Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat | |
| SE438856B (sv) | Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat | |
| FI791562A (fi) | Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat | |
| NO772960L (no) | Fremgangsmaate til fremstilling av cefalosporinderivater | |
| SE443140B (sv) | Forfarande for framstellning av karbostyrilderivat | |
| SE7707407L (sv) | Forfarande for framstellning av cefamderivat | |
| SE431336B (sv) | Analogiforfarande for framstellning av substituerade 8-azapurinderivat | |
| SE7707621L (sv) | Forfarande for framstellning av xyloslosning | |
| NO773073L (no) | Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater | |
| RO77308A (ro) | Procedeu pentru prepararea derivatiilor aminochinazolinei substituite | |
| SE436744B (sv) | Forfarande for framstellning av prostacyklinderivat | |
| SE7714123L (sv) | Forfarande for framstellning av imidazolderivat | |
| SE419083B (sv) | Analogiforfarande for framstellning av nikotinoylamino-triazinderivat | |
| SE7706515L (sv) | Forfarande for fornetning av plymerer | |
| DK531977A (da) | Fremgangsmaade til fremstilling af imidazolderivater | |
| SE443778B (sv) | Forfarande for framstellning av aryletrar av hydroxiaminer | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| SE7703630L (sv) | Forfarande for framstellning av furfural | |
| SE431647B (sv) | Forfarande for framstellning av 2-nitroimidazolderivat |